Cargando…
Estimation of the Clinical and Economic Impact of an Improvement in Adherence Based on the Use of Once-Daily Single-Inhaler Triple Therapy in Patients with COPD
BACKGROUND: Adherence to treatment is key to achieve desired outcomes. In COPD, adherence is generally suboptimal and is impaired by treatment complexity. OBJECTIVE: To estimate the clinical and economic impact of an improvement in treatment adherence due to an increased use of once-daily single-inh...
Autores principales: | Miravitlles, Marc, Marín, Alicia, Huerta, Alicia, Carcedo, David, Villacampa, Alba, Puig-Junoy, Jaume |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360417/ https://www.ncbi.nlm.nih.gov/pubmed/32764910 http://dx.doi.org/10.2147/COPD.S253567 |
Ejemplares similares
-
Cost-effectiveness of combination therapy umeclidinium/vilanterol versus tiotropium in symptomatic COPD Spanish patients
por: Miravitlles, Marc, et al.
Publicado: (2016) -
Cost-Effectiveness Of Once-Daily Single-Inhaler Triple Therapy In COPD: The IMPACT Trial
por: Ismaila, Afisi S, et al.
Publicado: (2019) -
Cost-Effectiveness of Once-Daily Single-Inhaler COPD Triple Therapy in Spain: IMPACT Trial
por: Paly, Victoria Federico, et al.
Publicado: (2022) -
Cost-Effectiveness Analysis of a Once-Daily Single-Inhaler Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease (COPD) Using the FULFIL Trial: A Spanish Perspective
por: Schroeder, Melanie, et al.
Publicado: (2020) -
Economic Impact of Low Adherence to COPD Management Guidelines in Spain
por: Miravitlles, Marc, et al.
Publicado: (2021)